Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CoraBio is a life science tools company that specializes in innovative reagents and kits for protein analysis, particularly Western blotting. The company's flagship technology, CoraReady, enables researchers to detect multiple protein targets on a single Western blot simultaneously without the need for traditional stripping and reprobing methods. By streamlining the Western blot workflow, CoraBio's products reduce experimental time, minimize sample loss, and improve data consistency for academic and industrial researchers. The company was founded as a spin-out from the University of Virginia and is headquartered in Charlottesville, Virginia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CoraBioSciences.